U.S. regulators on Tuesday approved the second new anti-obesity drug in 13 years, Qsymia, for use with exercise and a good diet in people who are obese or overweight with certain medical problems.
The first-ever daily pill to help prevent against HIV was approved Monday by U.S. regulators for use in uninfected adults who are at risk for getting the virus that causes AIDS.
ScinoPharm Taiwan Ltd., one of the leading biotechnology companies in the country, said Friday it plans to invest NT$1.1 billion (US$37.6 million) in a project to manufacture high-potency injectable drugs for cancer treatment.
Taiwan's emergency rooms (ER) face a serious imbalance between the number of doctors and patients, with the former keen to leave their jobs while the latter tend to abuse medical services, a research noted yesterday.
The Department of Health proposed a set of solutions to the increasing shortage of emergency room (ER) doctors Saturday, amid accusations that they are underpaid and overworked. The solutions include a cash reward of NT$120,000 (US$4,008) per year for physicians who have completed ER training, enhancement of safe work environments and plans to encourage transfer of patients from ER to other units, according to a statement released by the department.
A simple urine test could soon reveal more about a person's bones than X-rays, U.S. researchers said Tuesday after publishing results of an early phase study funded by NASA.
The EU recently provided CE Marking for the use of a dual anti-platelet therapy (DAPT) for patients suffering from coronary artery disease. Instead of undergoing at least a year of further medications after a stent placement, patients can now take advantage of a reduced medication period of a minimum of three months.
A cheap off-patent drug that is commonly used for arthritis could be a wonder treatment for amoebic parasites that infect 50 million people each year, 70,000 of them fatally, a study on Sunday said.